NIKUNJ TYAGI

    DIN: 02451567

    For latest information about the director, visit MCA.

    NIKUNJ TYAGI is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 02451567. NIKUNJ TYAGI is/has been associated with 21 companies.

    This is just one director. Ask about the whole track record.

    Ask Prime Research

    Companies Associated With

    Company Designation Date of Appointment
    DAWNDELIGHT GOURMET LLP Designated Partner 01-Mar-2012
    YVNS Momkidsfashion LLP Designated Partner 28-Nov-2022
    SIRMOUR REMEDIES PRIVATE LIMITED Director 11-Feb-2017
    SHRIOM ORGANICS PRIVATE LIMITED Director 29-Jan-2020
    PHARMAFORCE MEDEX PRIVATE LIMITED Whole-time director 31-Dec-2020
    MEDIFORCE RESEARCH PRIVATE LIMITED Director 01-Nov-2019
    MEDIPACK INNOVATIONS PRIVATE LIMITED Director 29-Sep-2018
    SUMURJA SHAKTI PRIVATE LIMITED Director 24-Jan-2020
    MEDIFORCE HEALTHCARE PRIVATE LIMITED Director 10-Feb-2017
    CODELIGHT ECOMMERCE SOLUTIONS PRIVATE LIMITED Director 14-Nov-2012
    TIGER ROAR HEALTHCARE PRIVATE LIMITED Director 11-Aug-2015

    Past Companies Associated With

    Company Designation Date of Appointment Date of Cessation
    SIRMOUR REMEDIES PRIVATE LIMITED Additional Director 04-Jan-2017 11-Feb-2017
    SIRMOUR REMEDIES PRIVATE LIMITED Director 22-Aug-2005 30-Jun-2010
    PHARMAFORCE MEDEX PRIVATE LIMITED Additional Director 28-Jul-2020 31-Dec-2020
    PHARMAFORCE MEDEX PRIVATE LIMITED Director 31-Dec-2020 24-Jul-2023
    RELAX PHARMACEUTICALS PRIVATE LIMITED Additional Director 01-May-2013 09-Sep-2013
    RELAX PHARMACEUTICALS PRIVATE LIMITED Director 09-Sep-2013 26-Mar-2021
    MEDIPACK INNOVATIONS PRIVATE LIMITED Additional Director 30-Jul-2018 29-Sep-2018
    MEDIFORCE HEALTHCARE PRIVATE LIMITED Additional Director 03-Jan-2017 10-Feb-2017
    COPMED PHARMACEUTICALS PRIVATE LIMITED Additional Director 02-Jan-2017 08-Feb-2017
    COPMED PHARMACEUTICALS PRIVATE LIMITED Director 08-Feb-2017 25-Dec-2019

    “Assess financial performance of all companies under a director.”

    Ask Prime Research Explore for Sales